Adjusting for tumor purity (STAR Methods), we detected a trend of higher sample-wise correlation in tumors associated with clinical features such as higher grade (p = 0.006), chromosome 14 loss (p = 0.0006), and BAP1 mutations (p = 0.00004) (Figure 3B; Table S4). The gene discussed is BAP1; the disease is neoplasm.